Munafa Stock Market Course + Intraday & FNO calls 
UG NEWS why is United-guardian, Inc. price falling or rising
UG NEWS reasons for why stock price of United-guardian, Inc. is falling or rising
UG United Guardian is falling or rising technical reasons
Technical analysis forecast of United Guardian Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in United Guardian UG at this time. Stock is rising and might rise more.
It appears as if United Guardian UG gave a large move recently.
Stock of United Guardian (UG) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
UG United Guardian is falling or rising NEWS fundamental reasons
Drug regulator warns against prolonged use of painkillers, antibiotics India’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks including kidney complications and chronic kidney disease. The advisory urges patients to use these medicines only under me - NEWS as on 2026-09-22 indiatimes.com
Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavir Dr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir for HIV prevention. The agreement facilitates manufacturing and supply planning for 120 countries. This collaborati - NEWS as on 2026-09-17 indiatimes.com
Centre proposes easier norms for faster drug rollout India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug regulator. Import license processing timelines for new drugs will be halved to forty-five days. This move aims to im - NEWS as on 2026-09-15 indiatimes.com
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery INDV, IRWD, RLMD, LRMR and CRDL could offer significant upside as biotech sentiment improves, backed by catalysts and differentiated pipelines. - NEWS as on 2026-09-14 nasdaq.com
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite DirectionsAstrazeneca (NYSE:AZN) presented Phase III data for tozorakimab in chronic obstructive pulmonary disease, or COPD, at the 2026 European Respiratory Society Congress in Barcelona - NEWS as on 2026-09-13 nasdaq.com
More announcements and NEWS
UG United-guardian, Inc. current price & indicator signals
Recent prices of UG United-guardian, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 21 Mon Sep 2026 | 7.17 | 7.15 to 7.45 | -0.55% | 0.23 times |
| 18 Fri Sep 2026 | 7.21 | 7.14 to 7.36 | -0.28% | 0.83 times |
| 17 Thu Sep 2026 | 7.23 | 7.10 to 7.23 | 1.4% | 0.92 times |
| 16 Wed Sep 2026 | 7.13 | 7.04 to 7.18 | -0.14% | 0.49 times |
| 15 Tue Sep 2026 | 7.14 | 7.08 to 7.20 | -0.28% | 0.71 times |
| 14 Mon Sep 2026 | 7.16 | 7.15 to 7.20 | -0.14% | 0.87 times |
| 11 Fri Sep 2026 | 7.17 | 7.02 to 7.18 | -0.28% | 0.51 times |
| 10 Thu Sep 2026 | 7.19 | 7.06 to 7.52 | 1.55% | 2.19 times |
| 09 Wed Sep 2026 | 7.08 | 7.07 to 7.20 | -0.56% | 0.72 times |
| 08 Tue Sep 2026 | 7.12 | 7.03 to 7.20 | -0.28% | 1.56 times |
| 04 Fri Sep 2026 | 7.14 | 7.00 to 7.20 | 0.99% | 1.2 times |
| 03 Thu Sep 2026 | 7.07 | 7.02 to 7.20 | 0% | 1.05 times |
Videos related to: UG NEWS why is United-guardian, Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
